Journament

Keyword Connections - neuroendocrine tumors Keywords

Connection Type	Connection
Journals	cancer journal of community hospital internal medicine perspectives ultrasonography (seoul, korea)
Research Groups	No Research Group Connected
Bibliographies	[1] A case of madness resulting in a fortunate outcome; case report of a psychotic break as a result of cortisol secreting thymic neuroendocrine thymic tumor. [2] Modern ultrasound imaging of pancreatic tumors. [3] Outcomes of first-line long-acting octreotide treatment in non-functional, advanced gastroenteropancreatic neuroendocrine tumors. [4] Fine-Needle Aspiration Cytology in the Diagnosis of Pancreatic Neuroendocrine Tumors: A Single-Center Experience of 25 Cases. [5] Operative resection in early stage pancreatic neuroendocrine tumors in the United States: Are we over- or undertreating patients? [6] Minimally invasive versus open distal pancreatectomy for pancreatic neuroendocrine tumors: An analysis from the U.S. neuroendocrine tumor study group [7] Association Between Somatostatin Receptor Expression and Clinical Outcomes in Neuroendocrine Tumors. [8] microRNA-431 promotes metastasis of pancreatic neuroendocrine tumors by targeting DAB2IP, a RasGAP tumor suppressor. [9] Efficacy of Galium-68 DOTATATE PET/CT in the Detection of Metastasis Rate of Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors. [10] Efficacy and safety of modified endoscopic mucosal resection for rectal neuroendocrine tumors: a meta-analysis. [11] Pancreatic grade 3 neuroendocrine tumors behave similarly to neuroendocrine carcinomas following resection: a multi-center, international appraisal of the WHO 2010 and WHO 2017 staging schema for pancreatic neuroendocrine lesions. [12] CUX1—Transcriptional Master Regulator of Tumor Progression in Pancreatic Neuroendocrine Tumors [13] CUX1—Transcriptional Master Regulator of Tumor Progression in Pancreatic Neuroendocrine Tumors [14] tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors [15] treatment of advanced pancreatic neuroendocrine tumors: potential role of everolimus [16] diagnostic work-up of gastroenteropancreatic neuroendocrine tumors [17] primary cerebellar neuroendocrine tumors: chimeras or real entities? a case report with a 6-year follow-up [18] Chronotype: what role in the context of gastroenteropancreatic neuroendocrine tumors?